Search

everythinglearnresearchcommunity

for

Search:↓

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

Ebastine may promote hair regrowth by increasing cell growth through the ERK pathway.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

The combination of encorafenib and binimetinib caused few skin issues.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.

Epidermal growth factor helps hair recover after chemotherapy.

mTORC2 is crucial for healthy skin barrier by regulating lipids and filaggrin.

Using a special laser and skin medication together successfully cleared a skin condition in a pregnant woman.

Anti-angiogenic drugs do not worsen COVID-19 severity in lung cancer patients.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

Blocking the Hedgehog pathway may help overcome drug resistance in multiple myeloma.

Suppressing ODC activity reduces tumor growth in hair follicles.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Inhibiting ACE2 improves skin regeneration during tissue expansion.

Hedgehog pathway inhibitors could be effective in treating melanoma.

Sorafenib often causes skin side effects, indicating effective cancer treatment.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Cepharanthine can potentially treat gastric cancer by stopping tumor growth.

FGF18 treatment during hair's resting phase can protect against hair loss from radiation.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.